Page last updated: 2024-12-06

cm 40907

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

CM 40907: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID65835
CHEMBL ID122135
SCHEMBL ID2109167
MeSH IDM0131987

Synonyms (26)

Synonym
cm-40907
lodaxaprine
4-piperidinol, 1-(6-(2-chlorophenyl)-3-pyridazinyl)-
cm 40907
lodaxaprine [inn]
1-(6-(o-chlorophenyl)-3-pyridazinyl)-4-piperidinol
3-(4-hydroxypiperidino)-6-(4-chlorophenyl)pyridazine
1-(6-(2-chlorophenyl)-3-pyridazinyl)-4-piperidinol
lodaxaprina [spanish]
lodaxaprium [latin]
1-[6-(2-chlorophenyl)pyridazin-3-yl]piperidin-4-ol
CHEMBL122135
93181-81-8
unii-d59zq3vvmv
lodaxaprium
3-(4-hydroxypiperidyl)-6-(2'-chlorophenyl)pyridazine
d59zq3vvmv ,
lodaxaprina
USEZRIFSJXAMJD-UHFFFAOYSA-N
3-(4-hydroxy-piperidino)-6-(2-chlorophenyl)pyridazine
SCHEMBL2109167
DTXSID50239308
AKOS030218732
1-[6-(2-chlorophenyl)-3-pyridazinyl]-4-piperidinol
Q27276115
Z2681891706
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (8)

Assay IDTitleYearJournalArticle
AID114801Anticonvulsant activity in Clonic seizures when administered orally in mice1986Journal of medicinal chemistry, Mar, Volume: 29, Issue:3
Synthesis and activity of 6-aryl-3-(hydroxypolymethyleneamino)pyridazines in animal models of epilepsy.
AID40039Antagonist activity to generalized seizures Photically induced seizures in senegalese Papio papio baboons1986Journal of medicinal chemistry, Mar, Volume: 29, Issue:3
Synthesis and activity of 6-aryl-3-(hydroxypolymethyleneamino)pyridazines in animal models of epilepsy.
AID190465Antagonist activity to generalized seizures kindled amygdaloid seizures in rats1986Journal of medicinal chemistry, Mar, Volume: 29, Issue:3
Synthesis and activity of 6-aryl-3-(hydroxypolymethyleneamino)pyridazines in animal models of epilepsy.
AID114802Anticonvulsant activity in tonic seizures when administered orally in mice1986Journal of medicinal chemistry, Mar, Volume: 29, Issue:3
Synthesis and activity of 6-aryl-3-(hydroxypolymethyleneamino)pyridazines in animal models of epilepsy.
AID114817Sedative properties by the rotarod test1986Journal of medicinal chemistry, Mar, Volume: 29, Issue:3
Synthesis and activity of 6-aryl-3-(hydroxypolymethyleneamino)pyridazines in animal models of epilepsy.
AID114634Anticonvulsant activity in Maximal electroshock (MES) when administered orally in mice1986Journal of medicinal chemistry, Mar, Volume: 29, Issue:3
Synthesis and activity of 6-aryl-3-(hydroxypolymethyleneamino)pyridazines in animal models of epilepsy.
AID114623Evaluated for Bicuculline-induced seizures (anticonvulsant activity) when administered orally in mice.1986Journal of medicinal chemistry, Mar, Volume: 29, Issue:3
Synthesis and activity of 6-aryl-3-(hydroxypolymethyleneamino)pyridazines in animal models of epilepsy.
AID114622Evaluated for Bicuculline-induced lethality (anticonvulsant activity) when administered orally in mice.1986Journal of medicinal chemistry, Mar, Volume: 29, Issue:3
Synthesis and activity of 6-aryl-3-(hydroxypolymethyleneamino)pyridazines in animal models of epilepsy.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (40.00)18.7374
1990's3 (60.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.46

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.46 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.54 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.46)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (40.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other3 (60.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]